397 related articles for article (PubMed ID: 19287816)
1. Protection of the ischaemic heart: investigations into the phenomenon of ischaemic preconditioning.
Lochner A; Marais E; Genade S; Huisamen B; du Toit EF; Moolman JA
Cardiovasc J Afr; 2009; 20(1):43-51. PubMed ID: 19287816
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of myocardial apoptosis by ischaemic and beta-adrenergic preconditioning is dependent on p38 MAPK.
Moolman JA; Hartley S; Van Wyk J; Marais E; Lochner A
Cardiovasc Drugs Ther; 2006 Feb; 20(1):13-25. PubMed ID: 16552474
[TBL] [Abstract][Full Text] [Related]
3. p38 MAPK activation triggers pharmacologically-induced beta-adrenergic preconditioning, but not ischaemic preconditioning.
Marais E; Genade S; Strijdom H; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Dec; 33(12):2157-77. PubMed ID: 11735262
[TBL] [Abstract][Full Text] [Related]
4. CREB activation and ischaemic preconditioning.
Marais E; Genade S; Lochner A
Cardiovasc Drugs Ther; 2008 Feb; 22(1):3-17. PubMed ID: 18205034
[TBL] [Abstract][Full Text] [Related]
5. Kinases and phosphatases in ischaemic preconditioning: a re-evaluation.
Fan WJ; van Vuuren D; Genade S; Lochner A
Basic Res Cardiol; 2010 Jul; 105(4):495-511. PubMed ID: 20127248
[TBL] [Abstract][Full Text] [Related]
6. The significance of the washout period in preconditioning.
Salie R; Lochner A; Loubser DJ
Cardiovasc Ther; 2017 Jun; 35(3):. PubMed ID: 28118517
[TBL] [Abstract][Full Text] [Related]
7. Efficacy of ischaemic preconditioning in the eNOS overexpressed working mouse heart model.
du Toit EF; Genade S; Carlini S; Moolman JA; Brunner F; Lochner A
Eur J Pharmacol; 2007 Feb; 556(1-3):115-20. PubMed ID: 17157294
[TBL] [Abstract][Full Text] [Related]
8. Activation of p38 MAPK induced by a multi-cycle ischaemic preconditioning protocol is associated with attenuated p38 MAPK activity during sustained ischaemia and reperfusion.
Marais E; Genade S; Huisamen B; Strijdom JG; Moolman JA; Lochner A
J Mol Cell Cardiol; 2001 Apr; 33(4):769-78. PubMed ID: 11273729
[TBL] [Abstract][Full Text] [Related]
9. Myocardial triggers involved in activation of remote ischaemic preconditioning.
Donato M; Goyeneche MA; Garces M; Marchini T; Pérez V; Del Mauro J; Höcht C; Rodríguez M; Evelson P; Gelpi RJ
Exp Physiol; 2016 Jun; 101(6):708-16. PubMed ID: 27028009
[TBL] [Abstract][Full Text] [Related]
10. Myocardial adenosine does not correlate with the protection mediated by ischaemic or pharmacological preconditioning in rat heart.
Vasara E; Katharou I; Lazou A
Clin Exp Pharmacol Physiol; 2003; 30(5-6):350-6. PubMed ID: 12859425
[TBL] [Abstract][Full Text] [Related]
11. Role of cyclic nucleotide phosphodiesterases in ischemic preconditioning.
Lochner A; Genade S; Tromp E; Opie L; Moolman J; Thomas S; Podzuweit T
Mol Cell Biochem; 1998 Sep; 186(1-2):169-75. PubMed ID: 9774198
[TBL] [Abstract][Full Text] [Related]
12. Effects of hydrogen sulphide on ischaemia-reperfusion injury and ischaemic preconditioning in the isolated, perfused rat heart.
Bliksøen M; Kaljusto ML; Vaage J; Stensløkken KO
Eur J Cardiothorac Surg; 2008 Aug; 34(2):344-9. PubMed ID: 18455926
[TBL] [Abstract][Full Text] [Related]
13. The role of β-adrenergic receptors in the cardioprotective effects of beta-preconditioning (βPC).
Salie R; Moolman JA; Lochner A
Cardiovasc Drugs Ther; 2011 Feb; 25(1):31-46. PubMed ID: 21225332
[TBL] [Abstract][Full Text] [Related]
14. Possible role of cardiac mast cell degranulation and preservation of nitric oxide release in isolated rat heart subjected to ischaemic preconditioning.
Parikh V; Singh M
Mol Cell Biochem; 1999 Sep; 199(1-2):1-6. PubMed ID: 10544945
[TBL] [Abstract][Full Text] [Related]
15. The temporal relationship between p38 MAPK and HSP27 activation in ischaemic and pharmacological preconditioning.
Marais E; Genade S; Salie R; Huisamen B; Maritz S; Moolman JA; Lochner A
Basic Res Cardiol; 2005 Jan; 100(1):35-47. PubMed ID: 15526116
[TBL] [Abstract][Full Text] [Related]
16. Temperature preconditioning of isolated rat hearts--a potent cardioprotective mechanism involving a reduction in oxidative stress and inhibition of the mitochondrial permeability transition pore.
Khaliulin I; Clarke SJ; Lin H; Parker J; Suleiman MS; Halestrap AP
J Physiol; 2007 Jun; 581(Pt 3):1147-61. PubMed ID: 17395631
[TBL] [Abstract][Full Text] [Related]
17. Improved functional recovery by ischaemic preconditioning is not mediated by adenosine in the globally ischaemic isolated rat heart.
Cave AC; Collis CS; Downey JM; Hearse DJ
Cardiovasc Res; 1993 Apr; 27(4):663-8. PubMed ID: 8324802
[TBL] [Abstract][Full Text] [Related]
18. Melatonin prevents cardioprotection induced by a multi-cycle ischaemic preconditioning protocol in the isolated perfused rat heart.
Genade S; Ytrehus K; Lochner A
Cardiovasc J S Afr; 2006; 17(5):239-44. PubMed ID: 17117228
[TBL] [Abstract][Full Text] [Related]
19. Preconditioning of the ischaemic myocardium; involvement of the L-arginine nitric oxide pathway.
Vegh A; Szekeres L; Parratt J
Br J Pharmacol; 1992 Nov; 107(3):648-52. PubMed ID: 1472963
[TBL] [Abstract][Full Text] [Related]
20. Myocardial susceptibility to ischaemia/reperfusion in obesity: a re-evaluation of the effects of age.
Webster I; Salie R; Marais E; Fan WJ; Maarman G; Huisamen B; Lochner A
BMC Physiol; 2017 Mar; 17(1):3. PubMed ID: 28302152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
